Cooking the Books
The statistical games behind "off-label" prescription drug use.
Without greater oversight from medical journals, the public must rely on whistle-blowers to come forward, as with Neurontin (such folks collect a hefty bounty from damage awards). But it would certainly be better for our collective health if clinical studies were kept honest from the beginning.
Darshak Sanghavi is Slate's health care columnist. He is chief of pediatric cardiology and associate professor of pediatrics at the University of Massachusetts Medical School as well as the author of A Map of the Child: A Pediatrician's Tour of the Body. Follow him on Twitter.